This inventor holds 1 USPTO granted patent. Top assignee: Burroughs Wellcome Co.. Active years: 1983.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1983
Title: Mirjana V Bogunovic: Innovator in Heterocyclic Chemistry
Introduction
Mirjana V Bogunovic is a distinguished inventor based in Bromley, GB. She has made significant contributions to the field of heterocyclic chemistry, particularly through her innovative research and patent work. Her expertise has led to advancements that may have important implications in pharmaceutical applications.
Latest Patents
Mirjana holds a patent for "Heterocyclic chemicals, their preparation and use." This patent describes compounds of formula (III), where R.sup.5 is a single substituent in position 2 or 3 of the phenyl ring. When in the 2-position, R.sup.5 can be a chlorine atom, a methyl group, or a nitro group. R.sup.6 can be a hydrogen atom or a CO.CH.sub.3 group. These compounds can be prepared using methods analogous to those known in the art, such as the reaction of the corresponding nitrothiazolyl benzamide with the corresponding halo(di)acetamide. The compounds of formula (III) exhibit schistosomicidal activity and can be administered either as the compound alone or as a pharmaceutical formulation. Mirjana has 1 patent to her name.
Career Highlights
Mirjana has built a successful career at Burroughs Wellcome Co., where she has been instrumental in advancing research in her field. Her work has not only contributed to the scientific community but has also paved the way for potential therapeutic applications.
Collaborations
Throughout her career, Mirjana has collaborated with various professionals, including her coworker Peter J Islip. These collaborations have enriched her research and expanded the impact of her innovations.
Conclusion
Mirjana V Bogunovic is a notable figure in the realm of heterocyclic chemistry, with a patent that highlights her innovative contributions. Her work continues to influence the field and holds promise for future advancements in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile